Related Experiment Video

Updated: Aug 19, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Metabolic mechanisms of tumor resistance to T cell effector function

Candace M Cham1, Thomas F Gajewski

  • 1Department of Pathology, Department of Medicine, and the Ben May Institute, University of Chicago, Chicago, IL 60637, USA.

Immunologic Research
|March 22, 2005
PubMed

Insights

Tumors evade immune destruction by disrupting nutrient availability, hindering T-cell function. Modulating tumor metabolism can enhance anti-tumor immunity for effective cancer treatment.

Area of Science:

  • Immunology
  • Metabolic pathways
  • Cancer research

Background:

  • Tumors possess mechanisms to evade immune system detection and destruction.
  • Metabolic dysregulation within the tumor microenvironment is increasingly recognized as a key factor in immune evasion.
  • Effector T-cell activity is highly dependent on nutrient availability.

Purpose of the Study:

  • To review experimental evidence on the critical role of specific nutrients in T-cell function within the tumor microenvironment.
  • To elucidate the mechanisms by which tumors deplete essential nutrients, thereby inhibiting anti-tumor immune responses.
  • To propose a metabolic framework for enhancing immune-mediated tumor destruction.

Main Methods:

  • Literature review of experimental data on nutrient metabolism and T-cell function.
  • Analysis of mechanisms of nutrient depletion in the tumor microenvironment.
  • Synthesis of findings to conceptualize metabolic interventions.

Main Results:

  • Glucose, oxygen, tryptophan, and arginine are vital for optimal T-cell function.
  • Tumors actively deplete these essential nutrients in the surrounding microenvironment.
  • Nutrient deprivation impairs effector T-cell responses against tumors.

Conclusions:

  • Metabolic reprogramming of the tumor microenvironment is a critical mechanism of immune evasion.
  • Targeting nutrient availability presents a promising strategy to enhance anti-tumor immunity.
  • Modulating the metabolic interplay between T cells and tumors can improve cancer immunotherapy outcomes.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...